BeOne Medicines Ltd. — Director's Dealing 2018

Feb 13, 2018

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2017-12-31

Reporting Person: Wang Xiaodong (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-22	Ordinary Shares	G	36400	—	Disposed	12879311	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	224372	Indirect

Footnotes

F1: Bona fide gift of shares which is exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5.

F2: The total reported in Column 5 has been adjusted to correct an error in the total holding reflected in a Form 4 filed on June 30, 2017 and the subsequent Form 4s.

F3: These securities are held in a UTMA account for the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.